Discover the latest advancements in HIV prevention and how they offer hope for reducing infections, especially in the Black ...

Christian employers challenged the constitutionality of provisions in the Affordable Care Act requiring coverage for ...

Gilead Sciences’ already dominant position in HIV pre-exposure prophylaxis (PrEP) has been consolidated by a new study showing that its twice-yearly injectable drug was 100% effective in ...

While this type of drug, called pre-exposure prophylaxis (PrEP), has also been shown to be 99% effective in blocking HIV infections from sex in clinical trials, this is not necessarily the case in ...

Introduction Oral pre-exposure prophylaxis (PrEP) is a priority intervention for scale-up in countries with high HIV ...